Skip to content

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3

Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02950545
Enrollment
51
Registered
2016-11-01
Start date
2016-04-30
Completion date
2017-02-01
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Keywords

astigmatism, contact lens, driving

Brief summary

It is a common clinical practice to leave small amounts of astigmatism uncorrected in contact lens wearers. Therefore, some drivers who have astigmatism and wear contact lenses may experience blur while driving. The purpose of this study is to determine if correcting small amounts of astigmatism with contact lenses will improve driving safety.

Detailed description

The purpose of this randomized control trial is to compare visual performance and simulated driving performance of adults with astigmatism when wearing 1\*DAY ACUVUE® MOIST for ASTIGMATISM (toric), 1\*DAY ACUVUE® MOIST (spherical control), and 1\*DAY ACUVUE® MOIST (placebo) contact lenses. Adult subjects with nearsightedness and astigmatism will wear three types of soft contact lenses (placebo, spherical and toric in randomized order). Each subject will read letters on standard eye charts and complete vision and driving tests in a driving simulator. Subjects will repeat these tests with each lens type. Analyses will include an ANOVA to look for a main effect of lens condition, and separate contrasts to compare toric vs. spherical, toric vs. placebo, and spherical vs. placebo lenses. Investigating the lenses under simulated driving conditions, which involve eye movement demands, will lend insight into the potential advantages of toric over spherical contact lenses for driving safety.

Interventions

AcuVue Oasys Bandage Lenses with no prescription

DEVICESpherical Lenses

1-DAY ACUVUE® MOIST contact lenses

DEVICEToric Lenses

1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses

Sponsors

Johnson & Johnson Vision Care, Inc.
CollaboratorINDUSTRY
University of Virginia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult licensed driver * Ages 18-39 years * Corrected vision of 20/40 or better in each eye * Astigmatism between 0.75 and 1.75 diopters in each eye * Nearsightedness between 0 and -9 diopters in each eye * No active eye infection * No defective peripheral vision * No bifocal correction * Routinely wears toric contact lenses (more than 4 times per week) * Routinely drives a car (more than 4 times per week) * No history of motion, sea, or big screen (e.g. IMAX) sickness, and no persistent Simulation Adaptation Syndrome

Exclusion criteria

* Corrected vision worse than 20/40 in either eye * No astigmatism in either eye * Active eye infection * Defective peripheral vision * Wears bifocals * Wears contact lenses less than 4 times per week * Drives infrequently (less than 4 times per week)

Design outcomes

Primary

MeasureTime frameDescription
Tactical Composite Score1 dayThis scale measures driving performance in the simulator. It is the sum of the z scores from 15 different driving simulator variables related to braking, steering, speed control and judgment. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.

Secondary

MeasureTime frameDescription
Operational Composite Score1 dayThis scale measures driving-relevant visual performance. It is the sum of the z scores from 5 different driving simulator variables related to visual testing done in the simulator. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.

Countries

United States

Participant flow

Participants by arm

ArmCount
Crossover Order 1
Placebo, Spherical, Then Toric Lenses
9
Crossover Order 2
Placebo, Toric, Then Spherical Lenses
9
Crossover Order 3
Spherical, Placebo, Then Toric Lenses
7
Crossover Order 4
Spherical, Toric, Then Placebo Lenses
8
Crossover Order 5
Toric, Placebo, Then Spherical Lenses
8
Crossover Order 6
Toric, Spherical, Then Placebo Lenses
10
Total51

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Session 1 (70 Minutes)Withdrawal by Subject000001
Session 2 (70 Minutes)Withdrawal by Subject000010
Session 3 (70 Minutes)Withdrawal by Subject000001
Washout 1 (5 Minutes)Withdrawal by Subject100101
Washout 2 (5 Minutes)Withdrawal by Subject100000

Baseline characteristics

CharacteristicTotalCrossover Order 1Crossover Order 2Crossover Order 3Crossover Order 4Crossover Order 5Crossover Order 6
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
51 Participants9 Participants9 Participants7 Participants8 Participants8 Participants10 Participants
Operational composite
Placebo lenses
-4.06 sum of z scores
STANDARD_DEVIATION 4.64
-3.95 sum of z scores
STANDARD_DEVIATION 3.95
-4.91 sum of z scores
STANDARD_DEVIATION 4.15
-2.85 sum of z scores
STANDARD_DEVIATION 3.23
-0.78 sum of z scores
STANDARD_DEVIATION 4.51
-7.43 sum of z scores
STANDARD_DEVIATION 4.36
-4.40 sum of z scores
STANDARD_DEVIATION 6.28
Operational composite
Spherical lenses
2.01 sum of z scores
STANDARD_DEVIATION 1.25
1.28 sum of z scores
STANDARD_DEVIATION 1.32
1.76 sum of z scores
STANDARD_DEVIATION 1.27
1.61 sum of z scores
STANDARD_DEVIATION 0.6
3.15 sum of z scores
STANDARD_DEVIATION 1.12
2.70 sum of z scores
STANDARD_DEVIATION 0.74
1.52 sum of z scores
STANDARD_DEVIATION 1.39
Operational composite
Toric lenses
2.05 sum of z scores
STANDARD_DEVIATION 1.48
2.29 sum of z scores
STANDARD_DEVIATION 1.16
1.70 sum of z scores
STANDARD_DEVIATION 1.08
3.01 sum of z scores
STANDARD_DEVIATION 2.01
2.45 sum of z scores
STANDARD_DEVIATION 1.53
1.30 sum of z scores
STANDARD_DEVIATION 0.44
1.56 sum of z scores
STANDARD_DEVIATION 1.99
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
51 participants9 participants9 participants7 participants8 participants8 participants10 participants
Sex: Female, Male
Female
36 Participants4 Participants7 Participants4 Participants6 Participants7 Participants8 Participants
Sex: Female, Male
Male
15 Participants5 Participants2 Participants3 Participants2 Participants1 Participants2 Participants
Tactical composite
Placebo Lenses
-0.69 sum of z scores
STANDARD_DEVIATION 6.44
-8.93 sum of z scores
STANDARD_DEVIATION 6.42
-4.94 sum of z scores
STANDARD_DEVIATION 3
5.32 sum of z scores
STANDARD_DEVIATION 1.77
3.32 sum of z scores
STANDARD_DEVIATION 3.49
-0.58 sum of z scores
STANDARD_DEVIATION 5.77
2.80 sum of z scores
STANDARD_DEVIATION 2.82
Tactical composite
Spherical Lenses
0.37 sum of z scores
STANDARD_DEVIATION 5.22
0.99 sum of z scores
STANDARD_DEVIATION 6.27
2.26 sum of z scores
STANDARD_DEVIATION 5.66
-2.59 sum of z scores
STANDARD_DEVIATION 3.24
-4.67 sum of z scores
STANDARD_DEVIATION 4.73
3.53 sum of z scores
STANDARD_DEVIATION 3.39
2.78 sum of z scores
STANDARD_DEVIATION 1.81
Tactical composite
Toric Lenses
0.32 sum of z scores
STANDARD_DEVIATION 6
1.92 sum of z scores
STANDARD_DEVIATION 5
1.88 sum of z scores
STANDARD_DEVIATION 3.51
5.32 sum of z scores
STANDARD_DEVIATION 3.16
3.71 sum of z scores
STANDARD_DEVIATION 2.66
-5.18 sum of z scores
STANDARD_DEVIATION 4.55
-7.03 sum of z scores
STANDARD_DEVIATION 6.06

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 510 / 510 / 51
other
Total, other adverse events
2 / 512 / 513 / 51
serious
Total, serious adverse events
0 / 510 / 510 / 51

Outcome results

Primary

Tactical Composite Score

This scale measures driving performance in the simulator. It is the sum of the z scores from 15 different driving simulator variables related to braking, steering, speed control and judgment. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.

Time frame: 1 day

Population: All participants who completed the 3 simulated driving sessions and who had complete and accurate data records were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
All Study ParticipantsTactical Composite ScorePlacebo0.34 score on a scaleStandard Deviation 2.44
All Study ParticipantsTactical Composite ScoreSphere-0.01 score on a scaleStandard Deviation 2.65
All Study ParticipantsTactical Composite ScoreToric-0.33 score on a scaleStandard Deviation 2.77
Secondary

Operational Composite Score

This scale measures driving-relevant visual performance. It is the sum of the z scores from 5 different driving simulator variables related to visual testing done in the simulator. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.

Time frame: 1 day

Population: All participants who completed the 3 simulated driving sessions and who had complete and accurate data records were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
All Study ParticipantsOperational Composite ScorePlacebo-4.06 score on a scaleStandard Deviation 4.64
All Study ParticipantsOperational Composite ScoreSphere2.01 score on a scaleStandard Deviation 1.25
All Study ParticipantsOperational Composite ScoreToric2.05 score on a scaleStandard Deviation 1.48

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026